NCT02537756 is a NA clinical trial of Project Voice in Human Papillomavirus Vaccines, sponsored by University of Texas Southwestern Medical Center.

Who is sponsoring NCT02537756?

NCT02537756 is sponsored by University of Texas Southwestern Medical Center.

What drugs are being tested in NCT02537756?

Interventions in NCT02537756: Project Voice.

What condition does NCT02537756 study?

NCT02537756 studies Human Papillomavirus Vaccines.

Is NCT02537756 still recruiting?

NCT02537756 is currently completed. Last updated 18 May 2020.

Last reviewed 2020-05-18 · How we verify

NCT02537756

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination

Completed NA Last updated 18 May 2020

What this trial tests

NA trial testing Project Voice in Human Papillomavirus Vaccines in 737 participants. Completed in 26 October 2019.

Timeline

5 April 2016

Primary endpoint
26 July 2018

26 October 2019

Quick facts

Lead sponsor	University of Texas Southwestern Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	prevention
Enrollment	737
Start date	5 April 2016
Primary completion	26 July 2018
Estimated completion	26 October 2019
Sites	1 location across United States

Drugs / interventions tested

Project Voice

Conditions studied

Human Papillomavirus Vaccines — all drugs for Human Papillomavirus Vaccines →

Sponsor

University of Texas Southwestern Medical Center

Who can join

18 and older, any sex, with Human Papillomavirus Vaccines. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

HPV vaccine coverage among adolescents in the US is suboptimal. This is particularly true among traditionally underserved adolescents. Few parent-targeted interventions have focused on the parental decision-making process. Self-persuasion, generating one's own arguments for engaging in a behavior, may be an effective means to influence parents' motivation to vaccinate their children. In a three-phase study, investigators are using quantitative and qualitative research methods to develop and refine a tablet-based self-persuasion intervention for parents who are undecided about the HPV vaccine. This clinical trial submission focuses on the second phase of the study. The results of the second phase will inform the third phase of the trial (also registered in clinical trials).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Developing a Tablet-Based Self-Persuasion Intervention Promoting Adolescent HPV Vaccination: Protocol for a Three-Stage Mixed-Methods Study.
Tiro JA, Lee SC, Marks EG, Persaud D, et al · · 2016 · cited 9× · PMID 26825137 · DOI 10.2196/resprot.5092
Mechanisms of self-persuasion intervention for HPV vaccination: Testing memory and autonomous motivation.
Baldwin AS, Zhu H, Rochefort C, Marks E, et al · · 2021 · cited 7× · PMID 34138615 · DOI 10.1037/hea0001075

Verify or expand the search:

Other trials of Project Voice

Trials testing the same drug.

NCT02535845 — Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial · NA · terminated

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

NCT03849963 — Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain · recruiting
NCT06917183 — Developing Strategies for Implementation and Use of the Operating Room Black Box (ORBB) · NA · not yet recruiting
NCT05145309 — Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans · Phase 2 · not yet recruiting
NCT06552000 — Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer · NA · not yet recruiting
NCT07387666 — Imaging Acetadote Metabolism in Glioblastoma · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02537756 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Texas Southwestern Medical Center
Last refreshed: 18 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02537756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing